Trishula Therapeutics
PrivateLast Round
Spinoff
Aug 26, 2020
Company Overview
Trishula Therapeutics is a biotechnology company that develops cancer immunotherapies, specifically focusing on its first-in-class anti-CD39 antibody, TTX-030.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trishula Therapeutics Comparables
Compare Trishula Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tizona Therapeutics | 91% | |
| Arcus Biosciences | 83% | |
| Coherus BioSciences Inc | 81% | |
Trishula Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Spinoff | Aug 26, 2020 |
Trishula Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterWest Partners | Spinoff |
| Lightstone Ventures | Spinoff |
| MPM BioImpact | Spinoff |
| AbbVie Ventures | Spinoff |
| Abingworth | Spinoff |
| Canaan Partners | Spinoff |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2020
Raised a spinoff round with investors including Canaan Partners and AbbVie Ventures.
Trishula Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Trishula Therapeutics's valuation, stock price, and market status.